TCT-803 Safety and efficacy of bioresorbable coronary devices in clinical practice: 1-year final results from the multicenter prospective REPARA registry
Methods REPARA is a multicentre, prospective registry, designed to evaluate the efficacy and safety of the bioresorbable coronary device Absorb® in native coronary arteries in daily clinical practice. Primary objective is MACE at 12 months, including cardiac death, myocardial infarction, target lesi...
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Cardiology 2017-10, Vol.70 (18), p.B326-B327 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Methods REPARA is a multicentre, prospective registry, designed to evaluate the efficacy and safety of the bioresorbable coronary device Absorb® in native coronary arteries in daily clinical practice. Primary objective is MACE at 12 months, including cardiac death, myocardial infarction, target lesion revascularization and stent thrombosis. |
---|---|
ISSN: | 0735-1097 1558-3597 |
DOI: | 10.1016/j.jacc.2017.09.1013 |